ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioLineRx Initiates Phase 3 Study with BL-8040 as Novel Stem Cell Mobilization Treatment
May 04, 2017BioLineRx announced it met with the U.S. Food and Drug Administration (FDA) and gained clarity on the development program and the design of a Phase 3 pivotal study for BL-8040 as a novel stem cell mobilization treatment for autologous bone-marrow transpla
Pharma Sources Insight January 2025
